2020 Rivaroxaban Test Volume and Sales Forecasts: US, Europe, Japan-Hospitals, Commercial Labs, POC Locations

March 2020 | | ID: 2E415C882EAEN
Venture Planning Group

Abstracts

This new report from VPGMarketResearch provides analysis of Calcitonin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.

Geographic Coverage

France, Germany, Italy, Japan, Spain, UK, USA

Market Segmentation

Centralized Testing

• Hospitals
• Commercial/Private Laboratories

POC/Decentralized Testing

• Physician Offices/Group Practices
• Ambulatory Care Centers
• ICUs/CCUs
• Cancer Clinics
• Surgery Center

Contents

TEST ANALYSIS

Clinical significance, current diagnostic procedures, and emerging tests

GEOGRAPHIC COVERAGE

France, Germany, Italy, Japan, Spain, UK, USA

MARKET SEGMENTATION

CENTRALIZED TESTING

Hospitals
Commercial/Private Laboratories

POC/DECENTRALIZED TESTING

List Of Tables

LIST OF TABLES

France: Test Volume and Diagnostics Sales Forecasts By Market Segment
Germany: Test Volume and Diagnostics Sales Forecasts By Market Segment
Italy: Test Volume and Diagnostics Sales Forecasts By Market Segment
Japan: Test Volume and Diagnostics Sales Forecasts By Market Segment
Spain: Test Volume and Diagnostics Sales Forecasts By Market Segment
UK: Test Volume and Diagnostics Sales Forecasts By Market Segment
USA: Test Volume and Diagnostics Sales Forecasts By Market Segment